RCMT
RCM Technologies, Inc.20.92
-0.32-1.51%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
155.03MP/E (TTM)
12.23Basic EPS (TTM)
1.71Dividend Yield
0%Recent Filings
8-K
8-K
Q2 revenue surges 13%
RCM Technologies posted Q2 revenue of $78.2 million, up 13.0% from $69.2 million last year, with gross profit climbing 11.4% to $22.3 million. Net income held steady at $3.8 million, or $0.50 per diluted share, while adjusted EBITDA rose to $8.1 million from $7.2 million. Growth spanned all segments. Momentum builds in engineering.
10-Q
Q2 FY2025 results
RCM Technologies posted solid Q2 FY2025 results, with revenue climbing 13.0% year-over-year to $78.2M, fueled by 15.9% growth in Specialty Health Care from school clients and 17.8% in Engineering via aerospace and energy projects, while Life Sciences dipped 9.3% on project timing. Gross margin held steady at 28.5%, but operating income rose 13.4% to $6.6M as SG&A efficiency offset investments; diluted EPS edged up to $0.50 from $0.47, reconciling cleanly with 7.5M weighted shares. Cash from operations reached $8.8M YTD, supporting $5.5M in share repurchases, with $5.5M cash and $20.8M revolver availability against $34.0M borrowings at 6.2% effective rate. No material M&A closed this quarter. Yet customer concentration persists, as two clients drove over 35% of revenue.
8-K
Auditor switch completed
RCM Technologies dismissed WithumSmith+Brown as its independent auditor on June 30, 2025, and immediately engaged EisnerAmper LLP for the fiscal year ending January 3, 2026. The switch follows the remediation of a material weakness in IT controls and separation of duties, fully resolved by December 28, 2024. No disagreements arose with Withum. This change streamlines audit processes amid clean financial reporting.
10-Q
Q1 FY2025 results
RCM Technologies kicked off fiscal 2025 with revenue climbing 17.4% year-over-year to $84.5 million for the quarter ended March 29, 2025, fueled by strong gains in Engineering (up 36.7% to $32.1 million) and Specialty Health Care (up 13.4% to $43.3 million), though Life Sciences, Data and Solutions dipped 11.7% to $9.0 million. Gross margin slipped to 26.0% from 28.3%, yet operating income rose 12.8% to $6.6 million, with diluted EPS advancing to $0.54 from $0.48 on 7.7 million shares—checks out clean. Cash from operations surged to $16.7 million, driving a $11.6 million net debt paydown to $23.4 million under the $65 million line (maturing 2029, 6.0% effective rate), leaving $34.3 million available. Revenue swelled 17.4% q/q (derived), but two clients hog 34.1% of the pie. Solid momentum builds. Yet competition sharpens in staffing markets.
ACM
AECOM
98.35+0.39
CNTM
ConnectM Technology Solutions,
0.46-0.04
CTSH
Cognizant Technology Solutions
83.63-0.42
EME
EMCOR Group, Inc.
624.56+0.47
J
Jacobs Solutions Inc.
133.95-1.57
KBR
KBR, Inc.
42.59-0.49
RGP
Resources Connection, Inc.
5.21+0.05
RITR
Reitar Logtech Holdings Limited
1.21+0.11
RMTG
Regenerative Medical Technology
0.04+0.00
TTEK
Tetra Tech, Inc.
34.15-0.29